Embedded Files
Menopause Care Pathways: (1) Non-Hormone Replacement Therapy (HRT) Alternatives and (2) Optimal HRT Timing for Premature Ovarian Insufficiency
This project looks at two topics. Topic one looks at the use of non-HRT treatments for menopause symptoms. This is particularly important for those women who cannot or choose not to use HRT.
Topic two looks at the optimal time to start taking HRT, the dosage and the duration women should be on HRT for.
Transition of care in dementia
This project, due to be completed in September 2025, will look at how communication between healthcare professionals about medicines be optimised, especially at transitions of care, to achieve multi-disciplinary care for people living with dementia.
Link to protocol (coming soon)
Systematic Review of Current and Future Technologies for Audiology Services
Hearing problems affect many people, from young children to older adults. Audiology services help identify and manage these problems. However, these services can be hard to access, slow, and not always user-friendly. New technologies could change this, making hearing tests and treatments better and easier to use. Our review will look at new and upcoming technologies that could improve hearing tests. We want to know:
What new technologies for hearing tests are available now?
What future technologies are being developed?
How might these technologies change the way hearing tests are done?
For more information about this project visit the NIHR Funding and Awards page.
Population screening for dementia in adults
The initial aim of this project is to update a 2019 evidence review produced for the UK National Screening Committee by producing two evidence maps. An evidence map aims to gauge the volume and type of evidence relating to a specific topic. The relevant evidence is summarised, and a recommendation is made on whether the evidence is sufficient to justify a more in-depth evidence summary.
Evidence map 1 will address the following questions:
What is the volume and type of evidence available on the accuracy of screening tests used to detect MCI and/or any type of dementia?
What is the volume and type of evidence available on the pharmacological and non-pharmacological interventions used to treat asymptomatic or pre-symptomatic adults with MCI and/or any type of dementia identified through screening?
The horizon scanning evidence map aims to systematically identify emerging screening tests and interventions for dementia and MCI. Specifically, it will address the question 'What is the available evidence of active research or development (including clinical trials, observational studies, evidence syntheses, patents, or opinions) investigating:
Innovative screening tests, diagnostic tools, care pathways or risk assessment approaches for MCI and dementia
Novel interventions (both pharmacological and non-pharmacological) to prevent, delay or treat MCI and dementia'.
For more information about this project visit the NIHR Funding and Awards page.
Report abuse